BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7909280)

  • 1. Increased levels of intercellular adhesion molecule-1 in the serum of patients with systemic lupus erythematosus.
    Sfikakis PP; Charalambopoulos D; Vayiopoulos G; Oglesby R; Sfikakis P; Tsokos GC
    Clin Exp Rheumatol; 1994; 12(1):5-9. PubMed ID: 7909280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of serum levels of soluble intercellular adhesion molecule-1 with disease activity in systemic lupus erythematosus.
    Sari RA; Taysi S; Erdem F; Yilmaz O; Keleş S; Kiziltunç A; Odabaş AR; Cetinkaya R
    Rheumatol Int; 2002 Jan; 21(4):149-52. PubMed ID: 11843170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating intercellular adhesion molecule-1 in patients with systemic sclerosis.
    Sfikakis PP; Tesar J; Baraf H; Lipnick R; Klipple G; Tsokos GC
    Clin Immunol Immunopathol; 1993 Jul; 68(1):88-92. PubMed ID: 8099861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble adhesion molecules in pediatric rheumatic diseases.
    Bloom BJ; Miller LC; Blier PR
    J Rheumatol; 2002 Apr; 29(4):832-6. PubMed ID: 11950029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus.
    Gattorno M; Vignola S; Barbano G; Sormani MP; Sabatini F; Buoncompagni A; Picco P; Pistoia V
    J Rheumatol; 2000 Sep; 27(9):2251-5. PubMed ID: 10990243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
    Lim KL; Jones AC; Brown NS; Powell RJ
    Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating intercellular adhesion molecule 1 as a new activity marker in patients with systemic lupus erythematosus.
    Kling E; Bieg S; Boehme M; Scherbaum WA
    Clin Investig; 1993 Apr; 71(4):299-304. PubMed ID: 8097124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in Wegener's granulomatosis, systemic lupus erythematosus and chronic renal failure.
    Mrowka C; Sieberth HG
    Clin Nephrol; 1995 May; 43(5):288-96. PubMed ID: 7543387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dehydroepiandrosterone sulfate is positively correlated with soluble interleukin 2 receptor and soluble intercellular adhesion molecule in systemic lupus erythematosus.
    Straub RH; Zeuner M; Antoniou E; Schölmerich J; Lang B
    J Rheumatol; 1996 May; 23(5):856-61. PubMed ID: 8724298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum thrombomodulin-a reliable marker of disease activity in systemic lupus erythematosus (SLE): advantage over established serological parameters to indicate disease activity.
    Boehme MW; Raeth U; Galle PR; Stremmel W; Scherbaum WA
    Clin Exp Immunol; 2000 Jan; 119(1):189-95. PubMed ID: 10606982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased adhesion molecule levels in systemic lupus erythematosus: relationships with severity of illness, autoimmunity, metabolic syndrome and cortisol levels.
    da Rosa Franchi Santos LF; Stadtlober NP; Costa Dall'Aqua LG; Scavuzzi BM; Guimarães PM; Flauzino T; Batisti Lozovoy MA; Mayumi Iriyoda TV; Vissoci Reiche EM; Dichi I; Maes M; Colado Simão A
    Lupus; 2018 Mar; 27(3):380-388. PubMed ID: 29400123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis.
    Janssen BA; Luqmani RA; Gordon C; Hemingway IH; Bacon PA; Gearing AJ; Emery P
    Br J Rheumatol; 1994 Dec; 33(12):1112-6. PubMed ID: 7528085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis.
    Kaplanski G; Cacoub P; Farnarier C; Marin V; Grégoire R; Gatel A; Durand JM; Harlé JR; Bongrand P; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):55-64. PubMed ID: 10643700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
    Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
    Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble intercellular adhesion molecule-1 in paediatric connective tissue diseases.
    Laucella SA; Gaddi E; Balbaryski J; Giraudi V; Cuttica RJ
    Acta Paediatr; 1999 Apr; 88(4):399-403. PubMed ID: 10342537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of inflammation and atherosclerosis in Egyptian patients with systemic lupus erythematosus.
    Sabry AA; Elbasyouni SR; Kalil AM; Abdel-Rahim M; Mohsen T; Sleem A
    Nephrology (Carlton); 2006 Aug; 11(4):329-35. PubMed ID: 16889573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum amyloid P component-DNA complexes are decreased in systemic lupus erythematosus. inverse association with anti-dsDNA antibodies.
    Voss A; Nielsen EH; Svehag SE; Junker P
    J Rheumatol; 2008 Apr; 35(4):625-30. PubMed ID: 18278838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between soluble interleukin 2 receptor levels and antidouble stranded DNA antibody levels in patients with systemic lupus erythematosus.
    Ward MM; Dooley MA; Christenson VD; Pisetsky DS
    J Rheumatol; 1991 Feb; 18(2):235-40. PubMed ID: 2023217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Existence of a soluble form of CD50 (intercellular adhesion molecule-3) produced upon human lymphocyte activation. Present in normal human serum and levels are increased in the serum of systemic lupus erythematosus patients.
    Pino-Otín MR; Viñas O; de la Fuente MA; Juan M; Font J; Torradeflot M; Pallarés L; Lozano F; Alberola-Ila J; Martorell J
    J Immunol; 1995 Mar; 154(6):3015-24. PubMed ID: 7876564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.